The FNRS Board of Directors has awarded the AMG-Onco 2023 to Michael Herfs, FNRS Qualified Researcher, ULiège, for his project: Impact of human papillomavirus infections on stemness/differentiation properties of cervical junctional cells.
The FNRS Board of Directors has awarded the AMG-Onco 2023 to Michael Herfs, FNRS Qualified Researcher, ULiège, for his project: Impact of human papillomavirus infections on stemness/differentiation properties of cervical junctional cells.